PRA International Adds Senior VP of Late Phase Services

Hani Zaki Appointed to Leadership Role

RALEIGH, North Carolina, June 11, 2010 - PRA International, a leading Clinical Research Organization (CRO),
announced today the appointment of Hani S. Zaki as Senior Vice President of
our Late Phase Services (LPS). Mr. Zaki will be responsible for all aspects
of this group, which is focused on successful post-approval activities.

"PRA is very excited to be adding Mr. Zaki's depth of industry expertise
to our LPS team. Bringing someone of Hani's caliber to an already strong team
will further strengthen our ability to grow in this developing area," said
Steve Powell, Senior Vice President, Clinical Informatics & Late Phase
Services. "Hani joins PRA at a time of significant growth in LPS. Today's
post-approval market is offering more opportunities than ever due to global
trends for mandated studies and expansion of registries and risk mitigation
strategies required by regulators worldwide."

PRA's recent success in the late-phase market has been driven by the
leadership of Maria Harrison, PRA's Vice President of LPS, who will continue
her successful role leading LPS' operational management as well as the
development of the group's dynamic delivery model.

"We believe the combination of Maria's operational and scientific
knowledge and Hani's focused post-approval business acumen will provide our
customers with a world-class, global team," Powell said.

Mr. Zaki has more than 25 years of industry experience in both
operational and business development management in the pharmaceutical, CRO
and late-phase industries. Most recently, he served as corporate vice
president and general manager for another major CRO's post-approval division.
Mr. Zaki has held other commercial positions, such as VP of business
development for a global CRO, and has directed market development, licensing
and merger and acquisition activities in pharma. His operational experience
includes leading the US clinical anti-infective operations for Rhone-Poulenc
Rorer (now Sanofi Aventis). He holds a bachelor's in microbiology from
Rutgers College, a master's in public health in epidemiology from the Tulane
University School of Public Health & Tropical Medicine, and an MBA in
pharmaceutical marketing from St. Joseph's University.

Ms. Harrison has over 20 years of experience in managing all aspects of
drug development in both the pharmaceutical and CRO industries. Before
joining PRA, Ms. Harrison was the VP of operations in North America for
clinical and post-approval services at a large CRO, where she had overall
responsibility for all operational aspects of over 100 projects.

PRA's highly experienced LPS team assists sponsors with the
post-marketing process by planning and conducting safety-surveillance
studies, large simple trials, registries, restricted access programs and risk
management programs. Since 2006, PRA has conducted or provided related
services for more than 175 late phase studies in multiple therapeutic
indications in 42 countries.

About PRA International

PRA International conducts clinical trials in more than 75 countries
across 6 continents and provides services through all phases of clinical
development. PRA performs studies in all therapeutic areas, with
specialization in Oncology, Neurosciences, Respiratory/Allergy,
Cardiovascular and Infectious Diseases. In the last five years, PRA has
supported over 2,700 clinical trials through its 37 global offices.

PRA's therapeutic expertise, global reach and project experience,
combined with extensive local knowledge and our differentiating PERSONAL
ELEMENT enable our project teams to deliver consistent and on time
performance for our clients. This unique PRA philosophy - THE PERSONAL
ELEMENT - recognizes that true client service comes only from trained,
empowered and dedicated employees who are encouraged to use innovation and
their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit
www.PRAinternational.com, email Endpoints@PRAintl.com or call our
Global Headquarters at +1-919-786-8200.

Roger Boutin, Director of Marketing of PRA International, Inc., +1-434-951-3924